Bente Glintborg

Clinical Associate Professor

Department of Clinical Medicine
Blegdamsvej 3
2200 København N.
- bente.glintborg.01@regionh.dk
- https://ikm.ku.dk/
Phone: +4529291641

Member of:

Internal Medicine: Rheumatology

All
Research

Publication year:

All

31 - 40 out of 75Page size: 10

Sort by: Publication date

2022
Published
Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries
Delcoigne, B., Ljung, L., Provan, S. A., Glintborg, Bente, Hetland, Merete Lund, Grøn, K. L., Peltomaa, R., Relas, H., Turesson, C., Gudbjornsson, B., Michelsen, B. & Askling, J., 2022, In: Annals of the Rheumatic Diseases. 81, 6, p. 789-797 9 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis
Nissen, M., Delcoigne, B., Di Giuseppe, D., Jacobsson, L., Hetland, M. L., Ciurea, A., Nekvindova, L., Iannone, F., Akkoc, N., Sokka-Isler, T., Fagerli, K. M., Santos, M. J., Codreanu, C., Pombo-Suarez, M., Rotar, Z., Gudbjornsson, B., van der Horst-Bruinsma, I., Loft, A. G., Möller, B., Mann, H. & 12 others, Conti, F., Yildirim Cetin, G., Relas, H., Michelsen, B., Avila Ribeiro, P., Ionescu, R., Sanchez-Piedra, C., Tomsic, M., Geirsson, Á. J., Askling, J., Glintborg, Bente & Lindström, U., 2022, In: Rheumatology. 61, 12, p. 4741-4751 11 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries
Di Giuseppe, D., Lindström, U., Aaltonen, K., Relas, H., Provan, S., Gudbjornsson, B., Hetland, Merete Lund, Askling, J., Kauppi, M., Geirsson, A. J., Chatzidionysiou, K., Jørgensen, T. S., Dreyer, L., Michelsen, B., Jacobsson, L. & Glintborg, Bente, 2022, In: Rheumatology. 61, 9, p. 3647-3656 10 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Waiting for JAK inhibitor safety data
Kragstrup, T. W., Glintborg, Bente, Svensson, A. L., McMaster, C., Robinson, P. C., Deleuran, B. & Liew, D. F., 2022, In: RMD Open. 8, 1, 002236.
Research output: Contribution to journal › Journal article › Research › peer-review
2021
Published
Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: Does the choice of biological therapy matter?
Lindström, U., Bengtsson, K., Olofsson, T., Di Giuseppe, D., Glintborg, Bente, Forsblad-D'elia, H., Jacobsson, L. T. H. & Askling, J., 2021, In: Annals of the Rheumatic Diseases. 80, 11, p. 1445-1452 8 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry
Glintborg, B., Jensen, D. V., Engel, S., Terslev, L., Pfeiffer Jensen, M., Hendricks, O., Østergaard, M., Horskjær Rasmussen, S., Adelsten, T., Colic, A., Danebod, K., Kildemand, M., Loft, A. G., Munk, H. L., Pedersen, J. K., Østgård, R. D., Møller Sørensen, C., Krogh, N. S., Nørgaard Agerbo, J., Ziegler, C. & 1 others, Hetland, Merete Lund, 2021, In: RMD Open. 7, 2, e001649.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: Nationwide observational study emulating a randomised clinical trial
Nabi, H., Georgiadis, S., Loft, A. G., Hendricks, O., Andersen, M., Chrysidis, S., Colic, A., Danebod, K., Hussein, M. R., Kalisz, M. H., Kristensen, S., Lomborg, N., Manilo, N., Munk, H. L., Pedersen, J. K., Raun, J. L., Mehnert, F., Krogh, N. S., Hetland, Merete Lund & Glintborg, Bente, 2021, In: Annals of the Rheumatic Diseases. 80, 11, p. 1400-1409.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis
Lindström, U., Glintborg, Bente, Di Giuseppe, D., Schjødt Jørgensen, T., Gudbjornsson, B., Lederballe Grøn, K., Aarrestad Provan, S., Michelsen, B., Hetland, Merete Lund, Wallman, J. K., Nordström, D., Trokovic, N., Love, T. J., Krogh, N. S., Askling, J., Jacobsson, L. T. H. & Kristensen, Lars Erik Vølund, 2021, In: Rheumatology (Oxford, England). 60, 8, p. 3635-3645 11 p.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Lindström, U., Di Giuseppe, D., Delcoigne, B., Glintborg, B., Möller, B., Ciurea, A., Pombo-Suarez, M., Sanchez-Piedra, C., Eklund, K., Relas, H., Gudbjornsson, B., Love, T. J., Jones, G. T., Codreanu, C., Ionescu, R., Nekvindova, L., Závada, J., Atas, N., Yolbas, S., Fagerli, K. M. & 11 others, Michelsen, B., Rotar, Tomšič, M., Iannone, F., Santos, M. J., Avila-Ribeiro, P., Ørnbjerg, L. M., Østergaard, Mikkel, Jacobsson, L. T. H., Askling, J. & Nissen, M. J., 2021, In: Annals of the Rheumatic Diseases. 80, 11, p. 1410-1418 220097.
Research output: Contribution to journal › Journal article › Research › peer-review
Published
Effectiveness of a second biologic after failure of a non–tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis
Chatzidionysiou, K., Hetland, Merete Lund, Frisell, T., Di Giuseppe, D., Hellgren, K., Glintborg, Bente, Nordström, D., Peltomaa, R., Aaltonen, K., Trokovic, N., Kristianslund, E. K., Kvien, T. K., Provan, S. A., Gudbjornsson, B., Grondal, G., Dreyer, L., Kristensen, Lars Erik Vølund, Jørgensen, T. S., Jacobsson, L. T. H. & Askling, J., 2021, In: Journal of Rheumatology. 48, 10, p. 1512-1518 7 p.
Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 212553036

Department of Clinical Medicine

Bente Glintborg

Department of Clinical Medicine

Member of:

Internal Medicine: Rheumatology

Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

Waiting for JAK inhibitor safety data

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: Does the choice of biological therapy matter?

Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry

Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: Nationwide observational study emulating a randomised clinical trial

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Effectiveness of a second biologic after failure of a non–tumor necrosis factor inhibitor as first biologic in rheumatoid arthritis

Most downloads

Impact of red meat, processed meat and fibre intake on risk of late-onset chronic inflammatory diseases: prospective cohort study on lifestyle factors using the Danish 'Diet, Cancer and Health' cohort (PROCID-DCH): protocol

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

Does a mandatory non-medical switch from originator to biosimilar infliximab lead to increased use of outpatient healthcare resources? A register-based study in patients with inflammatory arthritis